Skip to main content
Signal8

MacKay Kimberly Banks

SEC insider (Form 3/4/5 filer). CIK 0001835699. Director at CTS CORP (CTS) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 18, 2025. Located in LISLE, IL.

Companies MacKay Kimberly Banks has filed insider reports for

  • CTS CORP (CTS): Director
  • WEST PHARMACEUTICAL SERVICES INC (WST): Officer, SVP, GC & Corporate Secretary
MacKay Kimberly Banks profile photo

MacKay Kimberly Banks

CIK: 0001835699

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CTS CORP logo
CTS

CTS CORP

Director
WEST PHARMACEUTICAL SERVICES INC logo
WST

WEST PHARMACEUTICAL SERVICES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    Feb 18, 2025
    Exercise
    Direct
    246 shares at avg. $211.00$52K
  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    Feb 18, 2025
    Tax Payment
    Direct
    93 shares at avg. $211.00$20K
  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    Feb 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.2K shares-
  • WEST PHARMACEUTICAL SERVICES INC logo
    WST

    WEST PHARMACEUTICAL SERVICES INC

    Feb 18, 2025
    Award

    Rst. Stock Unit

    Direct
    503 shares-

1-4 of 4